Profectus designs and develops preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy... Read more
Profectus designs and develops preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy... Read more
News
Nov 30, 2019
Business Medical Dialogues
Profectus Biosciences: Aurobindo Pharma to acquire Profectus BioSciences biz assets for Rs 80 crore
Nov 29, 2019
Medical Buyer
Profectus Biosciences: Aurobindo Gains On Plans To Acquire Business Assets From Profectus
Nov 29, 2019
Moneycontrol
Profectus Biosciences: Aurobindo Pharma share price up 2% on assets acquisition of US firm
Mar 25, 2019
Benzinga
Profectus Biosciences: Developing vaccines and therapies for the highly pathogenic Nipah and Hendra viruses
Oct 01, 2018
BioPortfolio
Profectus Biosciences: Profectus BioSciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24072018 Prices from USD $250
Sep 19, 2018
BioPortfolio
Profectus Biosciences: Profectus BioSciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09052018 Prices from USD $250
Aug 20, 2018
Philanthropy News Digest
Profectus Biosciences: CEPI, Partners Launch $36 Million Lassa Vaccine Collaboration
Aug 16, 2018
The Business Journals
Profectus Biosciences: Two Maryland biotechs get $36 million to aid in new vaccine development
May 29, 2018
4-traders
Profectus Biosciences: Blog Exposure - Emergent BioSolutions and Profectus BioSciences Receive Contract from CEPI to Develop Nipah Virus Vaccine
May 24, 2018
BioPortfolio
Profectus Biosciences: CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine
Profectus Biosciences Competitors
1
2
3
4
5
6
7
8
9
10